Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

NCT: NCT06880835 · RECRUITING

NCT IDNCT06880835
StatusRECRUITING
Start Date2025-06-05
Completion2026-12-31
SponsorJaeb Center for Health Research (OTHER)
First posted
Last updated

Brief Summary

This investigator-initiated study will enroll about 30 adults 18 to 65 years of age with type 1 diabetes (T1D) who are using the Tandem t:slim X2 insulin pump or Tandem Mobi insulin pump with Control-IQ or Control-IQ+ technology ("Control-IQ" which will refer to either Control-IQ or Control-IQ+). The study is being done to find out if inhaled insulin given for a meal is safer and better to use than a bolus of insulin through your pump when you exercise following a meal. Participants are asked to complete three study exercise visits in the clinic.

Frequently Asked Questions

What is Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery?

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery is a clinical trial registered under NCT06880835. Current status: RECRUITING.

What is the status of NCT06880835?

The current status of NCT06880835 (Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery) is: RECRUITING.

When did Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery start?

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery started on 2025-06-05.

Related Devices

K223213Tandem Mobi Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K233044Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. K240309Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. K241078Tandem Mobi Insulin Pump with interoperable technologyTandem Diabetes Care, Inc. K253074Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑